RE: Finnharps121 Aug 2015 11:30
hiya finn.
i don't have a strong view on short-term price movement, not
much a day trader generally (altho' playing a bit on bp currently)
... share had a very good strong run above 700 over relatively
short space on time on back of the nicely synergistic acquisition,
then positive media/analyst comment on that. but probably natural
anyway that there would be a consolidation/pause for breath after
such a good run, and then on top of that the market as a whole has
seen china/oil/greece/august hol issues so many shares down or
dampened. personally, i'm fairly satisfied with how clinigen has held
up in that context. seems to be some profit taking, but also buyers nibble.
but like i said, not much of a short-term trader, & global news shocks could
affect clin just as much as other shares. i am in with a nice 500s average,
& have various trailing stops set to lock in profits if there are nasty falls, so
happy to sit and wait. if no horrible shocks, i intend to take a profit slice
(maybe circa 20%) at 800, then another slice around 850. treating it as a
longish term investment (say, one or two years unless horror shows!)
obviously, depends too on one's overall view re pharma
sector, & how much one looks for increasing m&a activity.
- you'll have to form your own view re rylidan.
so far as i can see, he's never actually been
an investor in clinigen, and doesn't know much
about the company or the sector. appears perhaps
to have started posting here after he got irritated
because addicknt and I are not so keen on some
companies that he likes. (tho' addicknt & I also differ
on one or two, of course). --- but not relevant to clin sp.
atb.